ADAP Advocacy has released a new infographic about the 340B Drug Pricing Program, reinforcing the message of its earlier policy paper and commercial titled '340B PROGRAM: The Glue That Should Hold Our Healthcare System Together.' The infographic, published as part of the organization's 340B Project, connects the program's unfettered growth to a decline in charity care, rising healthcare executive compensation, and exploding patient medical debt.
Congress created the 340B Drug Pricing Program to extend federal resources and improve patient care, and the Affordable Care Act added requirements for hospitals to provide free care and financial aid to poor patients, also known as charity care. However, charity care continues to decline year after year. In 2025, 340B drug purchases rose above $100 billion across over 42,000 covered entities and over 32,000 pharmacies. The infographic argues that this growth is failing to deliver on the program's promise.
The new infographic continues ADAP Advocacy's '340B Too Big To Fail' national advocacy campaign. That campaign highlights hospitals' declining charity care, rising executive compensation, and growing patient medical debt. The infographic can be downloaded online at https://tinyurl.com/y6asjaw2.
This news matters because the 340B program is a critical component of the U.S. healthcare safety net. If the program's growth is not translating into improved charity care, it raises questions about whether the program is fulfilling its intended purpose. Patients, especially those living with HIV/AIDS and other chronic conditions, rely on these resources for access to care. The infographic's findings could fuel calls for greater oversight and reform of the 340B program, impacting hospitals, pharmacies, and patients nationwide.
ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. The organization works with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient educational programs, and foster greater community collaboration.
